Supernus Pharmaceuticals, Inc. - US8684591089 - Слияние

АО "ФИНАМ" сообщает, что поступила информация от СПБ БАНК АО о корпоративном действии «Слияние»

Реквизиты корпоративного действия
Референс корпоративного действия	1688731040
Код типа корпоративного действия	MRGR
Тип корпоративного действия	Слияние
Признак обязательности КД	MAND - Участие в корпоративном действии обязательное; дополнительные инструкции от владельца счета не требуются
Статус обработки	Обработка информации о корпоративном действии не завершена Возникновение события было подтверждено

Информация о ценных бумагах
Референс КД по ценной бумаге	Эмитент	Наименование ценной бумаги	Категория	ISIN	Номинальная стоимость
1688731040BNYDTC	Supernus Pharmaceuticals, Inc.		Акции	US8684591089

Детали корпоративного действия

Дополнительная информация, уточняющая содержание сообщения

THE FOLLOWING PREVIOUSLY ANNOUNCED CORPORATE EVENT HAS NOW BEEN UPDATED/CONFIRMED EVENT TYPE : MERGER OFFICIAL CORPORATE ACTION EVENT REFERENCE : US157518528 RECORD DATE : Unknown PAYMENT DATE : Unknown EXPECTED TO RECEIVE DATE : Unknown MEETING DATE : 15-Oct-2026 ACCRUED INTEREST INDICATOR : No RESTRICTION FLAG : No DISSENTER'S RIGHTS NOT APPLICABLE : YES OPTION AND PAYOUT DETAILS : CONVERSION DEBIT CREDIT INDICATOR : CREDIT NEW SECURITY NAME : INDIVIOR PHARMACEUTICALS USD 0.001 NEW SEC ID (ISIN) : US45579U1097 NEW SEC ID (CUSIP) : 45579U109 NEW SEC ID (SEDOL) : BTZRLN8 CONVERSION FORM : RATIO CONVERSION NUMERATOR : 1.5401 CONVERSION DENOMINATOR : 1.0 CONVERSION RATIO : 1.5401 CONVERSION DEBIT CREDIT INDICATOR : DEBIT NEW SECURITY NAME : SUPERNUS PHARMACEUTICALS USD 0.001 CONVERSION FORM : RATIO CONVERSION NUMERATOR : 1.0 CONVERSION DENOMINATOR : 1.0 CONVERSION RATIO : 1.0 FREE FORMAT TEXT OF EVENT : +++UPDATE AS ON OCTOBER 07, 2026+++ . HOLDERS ARE ADVISED THAT DTC HAS RECEIVED AN SEC FILING NOTIFYING US OF A STOCK MERGER. THE ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON OCTOBER 15,2026 AT 10.00 A.M. EASTERN TIME FOR MORE INFORMATION REGARDING THE EVENT PLEASE VISIT THE LINK TO REVIEW THE SEC FILING IN FULL HTTPS(COLON)(FORWARDSLASH)(FORWARDSLASH)WWW.SEC.GOV(FORWARDSLASH)EDGAR (FORWARDSLASH)SEARCH(FORWARDSLASH) FILER(COLON) SUPERNUS PHARMACEUTICALS, INC. FORM(COLON) FORM DEFM14A FILING DATE(COLON) 09.11.26 . +++END OF UPDATE+++ . +++UPDATE AS ON SEPTEMBER 18, 2026+++ . IMPORTANT NOTE FOR NON-RESIDENT ALIENS (NRA) CLIENTS SECTION 302 EVENT FOR U.S. FEDERAL INCOME TAX PURPOSES, YOUR PORTION OF THE CASH IN LIEU ASSOCIATED WITH THE MERGER PAYMENT MAY BE TREATED AS A DIVIDEND OR AS A PAYMENT OF PROCEEDS FROM A SALE OR EXCHANGE (PRINCIPAL) OF YOUR POTENTIAL PROPORTIONATE INTEREST IN ACQUIRER SHARES. DIVIDENDS PAID BY U.S. CORPORATIONS TO NON-U.S. SHAREHOLDERS ARE GENERALLY SUBJECT TO WITHHOLDING TAX, AT A RATE OF 30PERCENT, OR SUCH LOWER RATE AS MAY BE PROVIDED UNDER AN APPLICABLE INCOME TAX TREATY FOR FATCA COMPLIANT ACCOUNTS OR 30PERCENT FOR NON-FATCA COMPLIANT ACCOUNTS. CONVERSELY, A PAYMENT OF PROCEEDS OF A SALE OR EXCHANGE OF SHARES IS GENERALLY EXEMPT FROM U.S. WITHHOLDING TAX. FOR PURPOSES OF FULFILLING BNYS RESPONSIBILITIES AS A WITHHOLDING AGENT IN RESPECT OF THE MERGER PAYMENT, THE CASH IN LIEU WILL BE PAID AS PRINCIPAL, AND THE APPLICABLE WITHHOLDING WILL BE DEBITED FROM THE CLIENT ACCOUNT. YOUR BNY CONTACT WILL SEND YOU NOTICES, INCLUDING THE CERTIFICATION, FOR COMPLETION. IF YOU CERTIFY TO BNY THAT EITHER(COLON) (A) YOUR POTENTIAL PROPORTIONATE INTEREST IN ACQUIRER WAS MEANINGFULLY REDUCED AS A RESULT OF THE PAYMENT, OR (B) YOU EXCHANGED ALL OF YOUR SHARES OF TARGET STOCK SOLELY FOR THE MERGER PAYMENT AND YOU HAD NO INTEREST IN ANY ACQUIRER STOCK IMMEDIATELY AFTER THE MERGER, BNY WILL GENERALLY TREAT YOUR PORTION OF THE MERGER PAYMENT AS A PAYMENT OF PROCEEDS FROM A SALE OR EXCHANGE OF YOUR TARGET SHARES. IF A QUALIFYING CERTIFICATION IS RECEIVED, BNY WILL REVERSE THE WITHHOLDING DEBIT FROM THE ACCOUNT. THE COMPLETED, SIGNED, AND DATED FORMS SHOULD BE RETURNED TO THE SECTION 302 TAX GROUP MAILBOX. IF QUALIFICATIONS ARE NOT MET OR NO CERTIFICATION IS RETURNED TO BNY WITHIN 60 DAYS FROM ORIGINAL PAYMENT, BNY WILL REVERSE THE WITHHOLDING ORIGINALLY DEBITED AND THE ORIGINAL CORPORATE ACTION PAYMENT TO PRINCIPAL, AND WILL RE-POST THE CORPORATE ACTION PAYMENT AS A DIVIDEND AS WELL AS THE APPLICABLE NRA WITHHOLDING TAX FOR FATCA COMPLIANT ACCOUNTS OR 30PERCENT IN FATCA WITHHOLDING FOR NON-FATCA COMPLIANT ACCOUNTS. INTERMEDIARIES IN CONTRAST TO DIRECT OWNERS, INTERMEDIARIES SHOULD OBTAIN THE APPROPRIATE TAX CERTIFICATION FROM ITS ACCOUNT HOLDERS AND PROVIDE THE APPROPRIATE TAX CERTIFICATION(S) TO BNY THAT WILL ALLOW BNY TO DETERMINE THE PORTION OF THE PROCEEDS TO BE TREATED AS EITHER(COLON) (1) A SALE OR EXCHANGE OR (2) A DIVIDEND. WHERE THE INTERMEDIARY INDICATES THAT A PORTION OF THE MERGER PAYMENT SHOULD BE TREATED AS DIVIDEND, THE INTERMEDIARY SHOULD ALSO SPECIFY THE APPLICABLE WITHHOLDING TAX RATE. AFTER THE PAYMENT DATE OF THE EVENT, PLEASE REACH OUT TO YOUR BNY CONTACT TO OBTAIN THE CERTIFICATION FOR COMPLETION. THE COMPLETED, SIGNED, AND DATED FORMS SHOULD THEN BE RETURNED IN 60 DAYS FROM ORIGINAL PAYMENT. PLEASE TAKE GOOD NOTE OF THIS WHEN YOU INSTRUCT OR EXECUTE YOUR FX TO AVOID ANY DIRECT OR INDIRECT COST RELATED TO FX. TO AVOID ANY DUPLICATION OF YOUR FX PLEASE CHECK IF FX STANDING INSTRUCTIONS ARE IN PLACE FOR CORPORATE ACTIONS POSTINGS. PLEASE BE AWARE THAT THE FX INSTRUCTIONS WILL NOT BE APPLIED TO YOUR PAYMENT UNTIL YOU COMPLETE AND SUBMIT YOUR CERTIFICATION OR IF NO CERTIFICATION IS SUBMITTED ONCE THE 60 DAY WINDOW HAS PASSED. . +++END OF UPDATE+++ OFFEROR : Indivior Pharmaceuticals Inc SHOULD YOU HAVE ANY QUESTIONS CONCERNING THIS ADVICE, PLEASE CONTACT THE BANK OF NEW YORK. CONTACT NAME : APAC based clients:GCEAPAC(AT)bny.com OR +1 646 782 6850 EMEA based clients: GCEEMEA(AT)bny.com OR +44 161 687 4545 Americas based clients: PS(underscore)CSEInquiries(AT)bny.com OR +1 412 234 0660 DISCLAIMER : THIS ADVICE IS BASED UPON THE ANNOUNCEMENT OF THIS EVENT IN THE MARKET AND WHICH IS AVAILABLE TO BNY. ALL INFORMATION PROVIDED BY BNY IS DERIVED FROM SOURCES BELIEVED TO BE RELIABLE WITHIN THE INDUSTRY. PLEASE REFER TO ANY OFFERING DOCUMENTS THAT MAY BE AVAILABLE FROM THE ISSUER FOR COMPLETE DETAILS AND OFFERING TERMS. In this notice, BNY refers to the following: The Bank of New York, BNY CSD SA/NV, The Bank of New York SA/NV, The Bank of New York Trust Company, N.A., BNY Asset Servicing, B.V., BNY Trust of Delaware, BNY Trust Company of Illinois, The Bank of New York (International) LTD. (including its Luxembourg Branch), CIBC Mellon Global Securities Services Company and CIBC Mellon Trust Company